BOSTON, June 11, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the […]
PRINCETON, N.J., June 11, 2024 (GLOBE NEWSWIRE) — Origin Life Sciences, Inc., a clinical-stage biotechnology company developing a proprietary patented […]
Results Indicate that Shareholders have Decisively Elected Medallion’s Director Nominees and Supported the Company’s Approach to Executive Compensation – Both […]